The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheumatology Research Foundation Investigators’ Meeting Shares Advancements Toward a Cure

Rheumatology Research Foundation Investigators’ Meeting Shares Advancements Toward a Cure

September 7, 2016 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Jon Giles, MD; Joan Bathon, MD; and Foundation President Eric Matteson, MD, MPH, discuss Foundation-funded research at the poster reception of the Investigators’ Meeting.

Jon Giles, MD; Joan Bathon, MD; and Foundation President Eric Matteson, MD, MPH, discuss Foundation-funded research at the poster reception of the Investigators’ Meeting.

The Rheumatology Research Foundation hosted the 9th annual Investigators’ Meeting in Atlanta on June 24–25. As a requirement for Foundation innovative research and pilot grant recipients, Foundation-funded investigators meet annually to provide updates and status reports on the work they are doing to advance treatments and cures for rheumatic diseases. More than 50 attendees enjoyed presentations from 20 award recipients. They also networked with one another to foster potential collaborations and build partnerships.

You Might Also Like
  • Rheumatology Research Foundation Hosts 10th Annual Investigators’ Meeting in St. Louis
  • Rheumatology Research Foundation’s Annual Investigators’ Meeting Spotlights Latest Findings
  • Rheumatology Research Foundation Hosts Student, Resident Experience at ACR/ARHP Annual Meeting
Explore This Issue
September 2016
Also By This Author
  • The ACR/Vasculitis Foundation Release Three New Guidelines for Treatment of Vasculitis

“This was a very successful meeting,” said Eric Matteson, MD, MPH, president of the Rheumatology Research Foundation. “I heard great discussions throughout the halls with attendees exchanging thoughts and ideas that will fuel future projects. That is exactly what this meeting is supposed to be about.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Presentations demonstrated a variety of topics, all of which aimed to help improve treatments and care for people living with rheumatic diseases. Timothy Niewold, MD, from the Mayo Clinic, presented on his study, Type I Interferon as a Predictor of Anti-TNF Response. This research could determine if type I interferon (IFN) may be predictive of treatment response to TNF-α inhibitors in rheumatoid arth­ritis. “With this work, we might be able to spare people who would not respond to a drug, so that we can move them on to treatments that will work for them,” says Dr. Niewold.

A presentation from Iris Navarro-Millan, MD, MSPH, from the University of Alabama at Birmingham, described efforts to create an electronic tool to more efficiently record and access patient-reported outcomes. The rheumatic disease activity measurement tool, also known as READY, would allow patients to record their symptoms and learn about their medications. The information reported through the tool could be used by rheumatologists for treatment decisions, as well as by investigators to study data.

Attendees of the Rheumatology Research Foundation’s 2016 Investigators’ Meeting

Attendees of the Rheumatology Research Foundation’s 2016 Investigators’ Meeting

Christopher Ritchlin, MD, MPH, from the University of Rochester Medical Center, presented on his study, Serum, Cellular and Imaging Markers of Arthritis in Psoriasis Patients. This work seeks to identify biomarkers that could determine which psoriasis patients are most at risk for developing psoriatic arthritis. The study will also determine if systemic treatment of psoriatic skin disease can suppress subclinical psoriatic arthritis.

Inez Rogatsky, PhD, from the Hospital for Special Surgery, says that the diversity of topics is one of her favorite aspects of the meeting. “I like that it brings together people from different backgrounds. I can get exposed to things that I would otherwise never hear,” she says. Lindsey Criswell, MD, MPH, from the University of California San Francisco, agrees: “It is exciting to hear from other investigators. The work is always cutting edge and valuable for our patients.”

In conjunction with the Investigators’ Meeting, the Foundation also hosted the 2nd annual Partners in Rheumatology: Leadership Summit. This meeting consisted of representatives from 14 private organizations and federal institutes who have a strong interest in rheumatology and rheumatic diseases. Attendees discussed ways that the organizations can work together and share resources to build a more effective support system for the rheumatology community.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

2016 Calendar

Oct. 3 – Deadline

  • Career Development Bridge Funding Award: R Bridge application*
  • Career Development Bridge Funding Award: K Bridge application*

Oct. 4 – Deadline

  • Late-Breaking Abstract Submission—2016 ACR/ARHP Annual Meeting

Oct. 26 – Deadline

  • Advance Registration—2016 ACR/ARHP Annual Meeting

Nov. 1 – Deadline

  • Lawren H. Daltroy Health Professional Preceptorship application
  • Ephraim P. Engleman Endowed Resident Research Preceptorship application
  • Medical and Graduate Student Preceptorship application

Nov. 11–16 – Conference

  • 2016 ACR/ARHP Annual Meeting (Washington, D.C.)

Dec. 31 – Deadline

  • Last day to make your 2016 tax-deductible gift to the Rheumatology Research Foundation

For more information about these or any other ACR, ARHP or Rheumatology Research Foundation activities, visit www.rheumatology.org.

* Deadline has changed since last year.

Pages: 1 2 | Multi-Page

Filed Under: From the College Tagged With: advancement, Advocacy, cure, investigators, patient care, rheumatology, Rheumatology Research FoundationIssue: September 2016

You Might Also Like:
  • Rheumatology Research Foundation Hosts 10th Annual Investigators’ Meeting in St. Louis
  • Rheumatology Research Foundation’s Annual Investigators’ Meeting Spotlights Latest Findings
  • Rheumatology Research Foundation Hosts Student, Resident Experience at ACR/ARHP Annual Meeting
  • Rheumatology Research Foundation Funding Enables Potential Treatment Advancements

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)